VAY736 2ml AI clinical trials

Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

This study is testing a new way to give a drug called ianalumab for autoimmune diseases like lupus, Sjögren's, and rheumatoid arthritis. We are comparing different devices (pre-filled syringes and auto-injectors) to make sure they deliver the drug in the same way and are safe.